Dr Ray Lambert and Dr Marion Frenz explored the impacts on food business sites of operating to food safety standards, an area where evidence is limited.
Professor Asa Lindholm Dahlstrand, Professor Peter Jelfs, Dr Iain Evans and Rebecca Todd interrogated the respective roles of public and private funding for innovation and entrepreneurship in this CIMR Debate in Public Policy
Dr. Thanos Fragkandreas is one of our newly graduated Ph.D. students. In this short interview, he shares with us his Ph.D. dissertation, a study exploring the relationship between innovation and income inequality.
Researchers and leading practitioners in investment and green innovation shared insights into green finance and fintech in this CIMR Debate in Public Policy.
Our very successful series of online lunchtime seminars is continuing in the Summer term of 2021 with an exciting programme of events. The events take place on Wednesdays lunchtime.
Dr Gaby Slavcheva and Dr Mirella Koleva are not your average mother and daughter. Both holding PhDs in science, the pair moved away from academia to found Quantopticon, a company which aims to rapidly speed up the development of quantum components to bring this exciting new technology to market.
This timely debate was well-attended by experts in related fields, from practitioners to scholars in different stages of their career.
This book aims to develop a conceptual framework to evaluate knowledge transfer practices and outcomes, improve knowledge transfer metrics, surveys and evaluation frameworks, generate findings on what does and does not work, and propose related policy lessons.
Thanos Fragkandreas, Goethe University of Frankfurt and Centre for Innovation Management Research shared his research into the relationship between innovation and inequality at our latest Debate in Public Policy.
Vaccines to combat the threat of Covid-19 have been developed at an amazing speed – in under a year. And while the first vaccines to be approved came from the private sector using new mRNA technologies, the unsung heroes of the COVD-19 vaccine effort have been the publicly funded national universities and laboratories.